Targeted Auger Electron Radiotherapy of HER2-amplified Breast Cancer
Monoclonal antibodies (mAbs) conjugated to nuclear localization sequences (NLS) and labeled with Auger electron-emitters have great potential for targeted radiotherapy of cancer. This approach may be especially appropriate for the 25-30% of patients with breast cancer whose tumors display overexpres...
Main Author: | Costantini, Danny |
---|---|
Other Authors: | Reilly, Raymond Matthew |
Language: | en_ca |
Published: |
2009
|
Subjects: | |
Online Access: | http://hdl.handle.net/1807/17745 |
Similar Items
-
Targeted Auger Electron Radiotherapy of HER2-amplified Breast Cancer
by: Costantini, Danny
Published: (2009) -
Auger Electron-emitting Radioimmunotherapeutic (RIT) Agent Specific for Leukemic Stem Cells
by: Gao, Jin Hua
Published: (2012) -
Auger Electron-emitting Radioimmunotherapeutic (RIT) Agent Specific for Leukemic Stem Cells
by: Gao, Jin Hua
Published: (2012) -
Pre-Clinical Assessment of 177Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease
by: Diane E. Milenic, et al.
Published: (2011-12-01) -
111In-labeled Nimotuzumab Modified with Nuclear Localization Sequences (NLS): An Auger Electron-emitting Radiotherapeutic Agent for EGFR-overexpressing and Trastuzumab-resistant Breast Cancer
by: Fasih, Aisha
Published: (2011)